IP Library Granted Patent US 10,327,716
Granted Patent B2
US 10,327,716 · App. 15/807,383 · Granted Jun 25, 2019

Method and apparatus for emission guided radiation therapy

Inventor: Samuel Mazin (Menlo Park, CA)
Assignee: RefleXion Medical, Inc.
A61B6/037A61B6/0407A61B6/469A61B6/54A61B6/541A61N5/1067A61N5/1081G01T1/2978G01T1/2985A61N2005/109A61N2005/1052A61N2005/1072A61N2005/1074A61N2005/1087A61N2005/1089A61N2005/1091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,327,716
App. No.
15/807,383
Filed
Nov 8, 2017
Granted
Jun 25, 2019
Kind
B2
Art Unit
2884
USPC
250/363.04
Abstract

An apparatus comprising a radiation source, coincident positron emission detectors configured to detect coincident positron annihilation emissions originating within a coordinate system, and a controller coupled to the radiation source and the coincident positron emission detectors, the controller configured to identify coincident positron annihilation emission paths intersecting one or more volumes in the coordinate system and align the radiation source along an identified coincident positron annihilation emission path.

Claims (38)

1. A radiation therapy system comprising:

a gantry rotatable about a tumor region;

a radiation source mounted on the gantry;

a collimation assembly mounted on the gantry and disposed in a radiation path of the radiation source, wherein the configuration of the collimation assembly is adjustable while the gantry is rotating;

an array of positron annihilation emission detectors mounted along at least a circumferential length of the gantry and configured to detect positron annihilation emission paths from the tumor region; and

a controller in communication with the array of positron annihilation emission detectors and configured to construct a map from the detected positron annihilation emission paths, and wherein the controller is in communication with the radiation source and configured to direct radiation from the radiation source to the tumor region based on the map.

2. The system of claim 1 , wherein the controller is in communication with the gantry and is further configured to direct radiation while rotating the gantry and detecting positron annihilation emission paths.

3. The system of claim 2 , wherein the array of positron annihilation emission detectors is configured to detect positron annihilation emission paths from multiple tumor regions, and wherein the controller is configured to direct radiation from the radiation source to the multiple tumor regions from multiple gantry positions.

4. The system of claim 1 , wherein the controller is configured to direct radiation to the tumor region from multiple gantry positions.

5. The system of claim 1 , wherein the controller is further configured to construct an image of metabolic activity of the tumor region based on the map of positron annihilation emission paths.

6. The system of claim 1 , further comprising a motion system in communication with the controller, wherein the controller controls gantry rotation using the motion system.

7. The system of claim 1 , wherein the controller is further configured to record a dose of radiation directed to the tumor region.

8. The system of claim 7 , further comprising an MeV detector mounted on the gantry opposite the radiation source, and wherein the controller is in communication with the MeV detector and is configured to record the radiation dose based on MeV detector readings.

9. The system of claim 1 , wherein the controller is in communication with the collimation assembly and the collimation assembly comprises a multi-leaf collimator and collimator jaws.

10. The system of claim 9 , wherein the multi-leaf collimator is reconfigurable for each gantry position.

11. The system of claim 10 , wherein the controller is further configured to move the collimator jaws in coordination with the multi-leaf collimator.

12. The system of claim 1 , wherein the controller is in communication with the collimation assembly and is configured to change a configuration of the collimation assembly to direct radiation from the radiation source along the detected positron annihilation emission paths.

13. The system of claim 1 , wherein the controller is in communication with the gantry and the collimation assembly, and wherein the controller is configured to coordinate gantry rotation, collimation assembly configuration adjustment, and radiation source triggering to direct radiation to the tumor region along the detected positron annihilation emission paths.

14. The system of claim 1 , further comprising a plurality of radiation sources mounted on the gantry.

15. The system of claim 1 , wherein the tumor region comprises living tumor tissue.

16. The system of claim 1 , further comprising a table, wherein the gantry is rotatable about the table, and wherein the controller is configured to translate the table in steps and is configured to direct radiation to the tumor region at each table step.

17. A method for radiation therapy comprising:

identifying a volume of interest by detecting a plurality of positron annihilation emission paths from the volume of interest using an array of positron annihilation emission detectors mounted on a rotatable gantry;

constructing a map of positron annihilation emission path activity from the detected positron annihilation emission paths; and

directing radiation from a radiation source mounted on the rotatable gantry to the volume of interest based on the map of positron annihilation emission path activity, wherein directing radiation comprises adjusting a configuration of a collimation assembly that is disposed in a radiation path of the radiation source while rotating the gantry.

18. The method of claim 17 , wherein directing radiation from the radiation source is based on a map of positron annihilation emission path activity from a previous radiation therapy session.

19. The method of claim 17 , further comprising constructing an image of metabolic activity of the volume of interest based on the map of positron annihilation emission path activity.

20. The method of claim 19 , wherein directing radiation from the radiation source is based on an image of metabolic activity from a previous treatment session.

21. The method of claim 17 , wherein the volume of interest comprises cancer tissue.

22. The method of claim 17 , wherein the volume of interest comprises brain tissue.

23. The method of claim 17 , wherein the volume of interest comprises kidney tissue.

24. The method of claim 17 , wherein the volume of interest comprises lung tumor tissue.

25. The method of claim 17 , wherein the volume of interest comprises living tumor tissue.

26. The method of claim 17 , further comprising providing a radiotracer to the volume of interest.

27. The method of claim 26 , wherein the radiotracer is a PET radiotracer.

28. The method of claim 26 , wherein the radiotracer is a metabolic radiotracer.

29. The method of claim 26 , wherein the radiotracer comprises a positron-emitting radionuclide selected from the group consisting of fluorine-18, carbon-11, oxygen-15, and nitrogen-13.

30. The method of claim 17 , wherein the volume of interest is located on a table and the method further comprises translating the table in steps and directing radiation to the volume of interest at each table step.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 11, 2022
From: OXFORD FINANCE LLC
To: REFLEXION MEDICAL, INC.
Reel/Frame 060469/0862 →
SECURITY INTEREST Recorded Jul 11, 2022
From: REFLEXION MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 060619/0066 →
SECURITY INTEREST Recorded Apr 26, 2019
From: REFLEXION MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 049009/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2017
From: MAZIN, SAMUEL
To: REFLEXION MEDICAL, INC.
Reel/Frame 044077/0014 →
Continuity (7)
Continuation 14951194 · Nov 24, 2015
Continuation 14278973 · May 15, 2014
Continuation 13895255 · May 15, 2013
Continuation 13209275 · Aug 12, 2011
Continuation 12367679 · Feb 9, 2009
Provisional Application 61036709 · Mar 14, 2008
Related Publication 20180110483A1 · Apr 26, 2018
Cited By (9)
US 12,214,219 US 12,233,286 US 12,251,579 US 12,303,717 US 12,337,196 US 12,340,968 US 12,502,554 US 12,582,845 US 12,654,035